,
your personalized virtual assistant to find clinical trials. Go head, 
Gini F Fleming, MD
University of Chicago Medical CenterChicago, Illinois - 60637 University of Chicago ConsortiumChicago, Illinois - 60637-1470 (773-702-6712) University of ChicagoChicago, Illinois - 60637 |
- CLINICAL TRIALS 4
- CONDITIONS5
- INTERVENTIONS8
- SINCE2009
Cediranib and Olaparib in Combination for Recurrent Ovarian or Triple-Negative Breast Cancer
November 2009 - October 2014
RO4929097 in Treating Patients With Recurrent and/or Metastatic Epithelial Ovarian Cancer Fallopian Tube Cancer or Primary Peritoneal Cancer
July 2010 - November 2010
Study of Oral ENMD-2076 Administered to Patients With Ovarian Cancer
April 2010 - December 2011
A Study of ABT-888 in Combination With Carboplatin and Gemcitabine in Subjects With Advanced Solid Tumors
January 2010 - January 2012
Breast Neoplasms
Neoplasms
Ovarian Neoplasms
Peritoneal Neoplasms
Fallopian Tube Neoplasms
Laboratory Biomarker Analysis
Carboplatin
Enmd-2076
Gamma-Secretase Inhibitor Ro4929097
Gemcitabine
Cediranib
Olaparib
Veliparib (Abt-888)
